Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-15-133077
Filing Date
2015-04-16
Accepted
2015-04-16 14:33:38
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B4 d833047d424b4.htm 424B4 946917
2 GRAPHIC g833047g16i25.jpg GRAPHIC 69401
3 GRAPHIC g833047g18t46.jpg GRAPHIC 37945
4 GRAPHIC g833047g19p50.jpg GRAPHIC 47161
5 GRAPHIC g833047g38z81.jpg GRAPHIC 44564
6 GRAPHIC g833047g40s24.jpg GRAPHIC 74643
7 GRAPHIC g833047g48q32.jpg GRAPHIC 58130
8 GRAPHIC g833047g58p92.jpg GRAPHIC 62618
9 GRAPHIC g833047g59x81.jpg GRAPHIC 36862
10 GRAPHIC g833047g93q43.jpg GRAPHIC 18458
  Complete submission text file 0001193125-15-133077.txt   1568971
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-201813 | Film No.: 15774248
SIC: 2834 Pharmaceutical Preparations